Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UNSPECIFIED INGREDIENT for Factor viii deficiency: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where UNSPECIFIED INGREDIENT was used for Factor viii deficiency.

Most Reported Side Effects for UNSPECIFIED INGREDIENT

Side Effect Reports % Deaths Hosp.
Death 2,090 8.0% 2,089 308
Off label use 1,306 5.0% 324 483
Drug ineffective 1,227 4.7% 154 338
Completed suicide 1,190 4.6% 1,189 170
Nausea 1,041 4.0% 234 514
Fatigue 1,020 3.9% 167 402
Dyspnoea 934 3.6% 270 594
Pneumonia 903 3.5% 310 719
Asthenia 894 3.4% 237 506
Vomiting 877 3.4% 244 528
Diarrhoea 821 3.1% 152 457
Pain 701 2.7% 128 299
Dizziness 692 2.6% 88 283
Headache 681 2.6% 125 261
Pyrexia 658 2.5% 140 499

Other Indications for UNSPECIFIED INGREDIENT

Product used for unknown indication (6,768) Rheumatoid arthritis (394) Non-small cell lung cancer (276) Cardiac failure (261) Type 2 diabetes mellitus (229) Diffuse large b-cell lymphoma (210) Covid-19 (207) Malignant melanoma (186) Hiv infection (185) Suspected suicide (172)

Other Drugs Used for Factor viii deficiency

EMICIZUMAB-KXWH (6,532) ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (4,268) EFMOROCTOCOG ALFA (832) --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (722) ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (352) ANTI-INHIBITOR COAGULANT COMPLEX (317) EMICIZUMAB (315) DAMOCTOCOG ALFA PEGOL (310) EFANESOCTOCOG ALFA (292) ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (180)

Related Pages

UNSPECIFIED INGREDIENT Full Profile All Factor viii deficiency Drugs UNSPECIFIED INGREDIENT Demographics UNSPECIFIED INGREDIENT Timeline